Inventor · disambiguated record
Sara Colombetti
Also filed as: COLOMBETTI SARA
1 granted patent·4 pending applications·5 citations·filing 2017–2022
27Inventor score
Files withHOFFMANN LA ROCHE5
Top patents by PatentIndex Score
5 records- 0181US10596257B2Methods of treating CEA-positive cancers using PD-1 axis binding antagonists and anti-CEA/anti-CD3 bispecific antibodiesHOFFMANN LA ROCHE·Filed 2017·Granted Mar 24, 2020·5 cites·52 claims
- 0256US2024092856A1Combination therapy of pd-1-targeted il-2 variant immunoconjugates and fap/4-1bb binding moleculesHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 0355US2020376119A1Methods of treating cea-positive cancers using pd-1 axis binding antagonists and anti-cea/anti-cd3 bispecific antibodiesHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 0447US2020172627A1Type ii anti-cd20 antibody and anti-cd20/cd3 bispecific antibody for treatment of cancerHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 0544US2024173442A1Combination therapyHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sara Colombetti files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →